Praxis Precision Medicines Inc. (PRAX) Social Stream
PRAXIS PRECISION MEDICINES INC (PRAX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PRAXIS PRECISION MEDICINES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-02 | 5 | $65 | $28 | $46 | $43.49 | 5.77% |
| 2022-02-13 | 6 | $65 | $28 | $46.5 | $43.49 | 6.92% |
| 2022-04-27 | 6 | $65 | $27 | $45.5 | $43.49 | 4.62% |
| 2022-04-28 | 6 | $65 | $27 | $45 | $43.49 | 3.47% |
| 2022-05-13 | 6 | $65 | $26 | $43.25 | $43.49 | -0.55% |
| 2022-06-06 | 6 | $65 | $26 | $43.25 | $43.49 | -0.55% |
| 2022-08-13 | 6 | $18 | $4 | $9 | $43.49 | -79.31% |
| 2022-09-17 | 6 | $18 | $4 | $9.125 | $43.49 | -79.02% |
| 2022-11-11 | 5 | $18 | $3 | $8.875 | $43.49 | -79.59% |
| 2023-01-30 | 6 | $18 | $3 | $8.875 | $43.49 | -79.59% |
| 2023-02-08 | 6 | $18 | $3 | $10.375 | $43.49 | -76.14% |
| 2023-03-06 | 6 | $18 | $2 | $10.125 | $43.49 | -76.72% |
| 2023-04-18 | 5 | $18 | $2 | $10.125 | $43.49 | -76.72% |
| 2023-05-12 | 5 | $18 | $1.5 | $9.375 | $43.49 | -78.44% |
| 2023-08-09 | 6 | $18 | $1.5 | $8.1 | $43.49 | -81.38% |
| 2023-08-10 | 7 | $18 | $1.5 | $6.5 | $43.49 | -85.05% |
| 2023-11-07 | 7 | $18 | $1.5 | $7.083 | $43.49 | -83.71% |
| 2023-11-15 | 7 | $18 | $1 | $6.916 | $43.49 | -84.1% |
| 2023-11-30 | 7 | $269.865 | $16 | $103.874 | $43.49 | 138.85% |
| 2023-12-06 | 7 | $270 | $16 | $103.909 | $43.49 | 138.93% |
The Trend in the Analyst Price Target
Over the past 30 months, PRAX's average price target has gone up $40.58.
PRAX reports an average of 840.36% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-06 | 6 | 18.000 | 2.0 | 10.125 | 1.110 | 812.16% |
| 2023-05-12 | 5 | 18.000 | 1.5 | 9.125 | 1.040 | 777.4% |
| 2023-06-09 | 6 | 18.000 | 1.5 | 8.100 | 0.988 | 719.84% |
| 2023-11-08 | 7 | 18.000 | 1.0 | 6.916 | 1.000 | 591.6% |
| 2023-11-30 | 7 | 269.865 | 16.0 | 103.874 | 18.200 | 470.74% |
PRAX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.57 | 5 | 0 | 2 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 22 months, PRAX's average broker recommendation rating worsened by 0.57.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRAX as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, PRAXIS PRECISION MEDICINES INC's variance in analysts' estimates is lower than -2175.84% of them.
- PRAXIS PRECISION MEDICINES INC's upside potential (average analyst target price relative to current price) is higher than 405.08% of all US stocks.
- In the context of stocks in the mid market cap category, PRAXIS PRECISION MEDICINES INC's average analyst price target is greater than 702.47% of them.
- PRAX has a higher number of analysts covering the stock than 769.74% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, MLTX, AVIR, and VALN are the three stocks most similar to PRAXIS PRECISION MEDICINES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for PRAX? Use POWR Ratings for clearer insight into price direction.